{
    "clinical_study": {
        "@rank": "114493", 
        "arm_group": {
            "arm_group_label": "BGJ398", 
            "arm_group_type": "Experimental", 
            "description": "To estimate anti-tumor activity of BGJ398"
        }, 
        "brief_summary": {
            "textblock": "This is a multi-center, open label, single arm phase II study evaluating BGJ398 anti-tumor\n      activity in advanced or metastatic cholangiocarcinoma patients with FGFR genetic\n      alterations."
        }, 
        "brief_title": "A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma", 
        "completion_date": {
            "#text": "July 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Advanced Cholangiocarcinoma", 
        "condition_browse": {
            "mesh_term": "Cholangiocarcinoma"
        }, 
        "detailed_description": {
            "textblock": "Adult patients with histologically or cytologically confirmed advanced or metastatic\n      cholangiocarcinoma with FGFR2 gene fusion/ translocation or other FGFR genetic alteration\n      who have evidence of radiologic progression following a cisplatin-and gemcitabine-containing\n      regimen for advanced disease or a gemcitabine-containing regimen for those who are\n      considered intolerant to cisplatin will be enrolled.  Approximately 55 adult patients over\n      age 18, both male and female will be enrolled. Of these 55 patients, 40 patients will have\n      cholangiocarcinoma with identified FGFR2 gene fusions and up to 15 patients may have other\n      FGFR genetic alterations. All patients will receive oral BGJ398, once daily, on a three\n      weeks on (21 days), one week off (7 days) schedule. One treatment cycle will consists of 28\n      days."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Main inlcusion criteria:\n\n          -  Patients with histologically or cytologically confirmed cholangiocarcinoma at the\n             time of diagnosis.\n\n          -  Patients must have received at least one prior regimen containing gemcitabine with or\n             without cisplatin for advanced or metastatic disease. Patient must have evidence of\n             progressive disease following prior regimen.\n\n        Main exclusion criteria:\n\n          -  Prior or current treatment with an FGFR inhibitor\n\n          -  insufficient organ function\n\n               -  ANC < 1,000/mm3 [1.0 x 109/L]\n\n               -  Platelets < 75,000/mm3 [75 x 109/L]\n\n               -  Hemoglobin < 109.0 g/dL\n\n               -  Total bilirubin > 1.5x ULN\n\n               -  AST/SGOT and ALT/SGPT > 2.5x ULN (AST and ALT > 5x ULN in the presence of  liver\n                  metastases)\n\n               -  Serum creatinine > ULN and/or calculated or measured creatinine clearance < 75%\n                  LLN\n\n               -  Inorganic phosphorus outside of normal limits\n\n               -  Total and ionized serum calcium outside of normal limits"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "55", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02150967", 
            "org_study_id": "CBGJ398X2204", 
            "secondary_id": "2013-005085-19"
        }, 
        "intervention": {
            "arm_group_label": "BGJ398", 
            "description": "Capsule for oral use", 
            "intervention_name": "BGJ398", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "cholangiocarcinoma,", 
            "FGFR2 gene fusion,", 
            "FGFR genetic alteration"
        ], 
        "lastchanged_date": "May 27, 2014", 
        "location": [
            {
                "contact": {
                    "email": "Mihalik.laurie@mayo.edu", 
                    "last_name": "Laurie Mihalik", 
                    "phone": "480-342-3256"
                }, 
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona"
                    }, 
                    "name": "Mayo Clinic - Arizona Dept of Oncology"
                }, 
                "investigator": {
                    "last_name": "Mitesh J. Borad", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "CMaravola@mednet.ucla.edu", 
                    "last_name": "Christine Maravola", 
                    "phone": "310-582-6324"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }, 
                    "name": "University of California at Los Angeles UCLA SC"
                }, 
                "investigator": {
                    "last_name": "Saeed Sadeghi", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Zeno.Ashai@med.usc.edu", 
                    "last_name": "Zeno Ashai", 
                    "phone": "323-865-3957"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "USC/Kenneth Norris Comprehensive Cancer Center Onc Dept"
                }, 
                "investigator": {
                    "last_name": "Anthony El-Khoueiry", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jregalad@nmh.org", 
                    "last_name": "Jane Regalado", 
                    "phone": "312-695-4168"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "NorthwesternUniv.Med.School/Robert H. Lurie Comp.Cancer Ctr Onc Dept"
                }, 
                "investigator": {
                    "last_name": "Al Benson", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "alomeara@partners.org", 
                    "last_name": "Ashley O'Meara", 
                    "phone": "617-724-9533"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts General Hospital Dept. of Mass General Hospital"
                }, 
                "investigator": {
                    "last_name": "Andrew Zhu", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "budded@karmanos.org", 
                    "last_name": "David Budde", 
                    "phone": "313-576-9385"
                }, 
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201"
                    }, 
                    "name": "Wayne State University/Karmanos Cancer Institute Onc. Department"
                }, 
                "investigator": {
                    "last_name": "Philip A. Philip", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Oneillg@mskcc.org", 
                    "last_name": "Gerry O'Neill", 
                    "phone": "646-888-4330"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Memorial Sloan Kettering Cancer Center Sloan Onc Dept."
                }, 
                "investigator": {
                    "last_name": "Ghassan K. Abou-Alfa", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Ivy.cohen@mssm.edu", 
                    "last_name": "Ivy S. Cohen", 
                    "phone": "212-824-7319"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Mount Sinai School of Medicine Onc Dept."
                }, 
                "investigator": {
                    "last_name": "Celina Ang", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "sona.hardikar@osumc.edu", 
                    "last_name": "Sona Hardikar", 
                    "phone": "614-293-9863"
                }, 
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43210"
                    }, 
                    "name": "Ohio State Comprehensive Cancer Center/James Cancer Hospital Dept of Onc"
                }, 
                "investigator": {
                    "last_name": "Tanios Bekaii-Saab", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "saziz@mdanderson.org", 
                    "last_name": "Samia Aziz", 
                    "phone": "713-563-7757"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030-4009"
                    }, 
                    "name": "University of Texas/MD Anderson Cancer Center Onc. Dept,"
                }, 
                "investigator": {
                    "last_name": "Milind Javle", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69437"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier Cedex 5", 
                        "country": "France", 
                        "zip": "34298"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barnaul", 
                        "country": "Russian Federation", 
                        "zip": "656045"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "115478"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "125367"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Singapore", 
                        "country": "Singapore", 
                        "zip": "169610"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Singapore", 
                        "country": "Singapore", 
                        "zip": "119228"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "state": "Catalunya", 
                        "zip": "08035"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28050"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand", 
                        "zip": "10330"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand", 
                        "zip": "10400"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Khon Kaen", 
                        "country": "Thailand", 
                        "zip": "40002"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "France", 
                "Russian Federation", 
                "Singapore", 
                "Spain", 
                "Thailand"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase II Multicenter, Single Arm Study of Oral BGJ398 in Adult Patients With Advanced or Metastatic Cholangiocarcinoma With FGFR2 Gene Fusions or Other FGFR Genetic Alterations Who Failed or Are Intolerant to Platinum-based Chemotherapy", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "1-888-669-6682"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone_ext": "+41613241111"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Thailand: Food and Drug Administration", 
                "France: National Agency for the Safety of Medicines and Health Products (MSNA)", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Italy: The Italian Medicines Agency", 
                "Singapore: Clinical Trials & Epidemiology Research Unit (CTERU)", 
                "Japan: Pharmaceuticals and Medical Devices Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Overall response rate (ORR) is defined as the proportion of patients with a best overall response of Complete Response (CR) or Partial Response (PR), as per RECIST version 1.1.", 
            "measure": "Overall response rate (ORR)", 
            "safety_issue": "No", 
            "time_frame": "up to 24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02150967"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Overall Survival (OS) is defined as the time from the date of start of treatment to the date of death due to any cause.", 
                "measure": "Overall survival", 
                "safety_issue": "No", 
                "time_frame": "up to 24 months"
            }, 
            {
                "description": "Progression free survival (PFS) is defined as the date of the start of treatment to the date of the event defined as the first documented progression or death due to any cause.", 
                "measure": "Progression free survival", 
                "safety_issue": "No", 
                "time_frame": "up to 24 months"
            }, 
            {
                "description": "The best overall response is the best response recorded from the start of the treatment until disease progression.", 
                "measure": "Best overall response", 
                "safety_issue": "No", 
                "time_frame": "up to 24 months"
            }, 
            {
                "description": "Disease control rate (DCR) is the proportion of patients with a best overall response of CR or PR or SD.", 
                "measure": "Disease control rate", 
                "safety_issue": "No", 
                "time_frame": "up to 24 months"
            }, 
            {
                "description": "To characterize the safety and tolerability of single agent BGJ398 by the type, frequency and severity of AEs & SAEs.", 
                "measure": "Number of participants with adverse events (AEs) and serious adverse events (SAEs) as a measure of safety and tolerability", 
                "safety_issue": "Yes", 
                "time_frame": "up to 24 months"
            }, 
            {
                "description": "To determine selected trough and 2-hr plasma concentrations of BGJ398", 
                "measure": "Selected trough and 2-hr Plasma concentration profile", 
                "safety_issue": "Yes", 
                "time_frame": "up to 12 months"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}